Skip to main content

Kryptos Biotechnologies

Hayward, United States

Kryptos Biotechnologies provides innovative life science systems that reveal the complexity of biology for clinicians and scientists.

$10.0M raised
Mar 2024
Series A

Top Investors

SkyDeck BerkeleyCoolidge Corner InvestmentLG ChemFuturePlayOsang Healthcare

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Kryptos Biotechnologies

How much funding has Kryptos Biotechnologies raised?
Kryptos Biotechnologies has raised $10.0M in total funding. The most recent round was Series A. The last funding was announced in March 2024.
Who are Kryptos Biotechnologies's investors?
Kryptos Biotechnologies's investors include SkyDeck Berkeley, Coolidge Corner Investment, LG Chem, FuturePlay, Osang Healthcare.
Where is Kryptos Biotechnologies headquartered?
Kryptos Biotechnologies is headquartered in Hayward, United States.
What does Kryptos Biotechnologies do?
Kryptos Biotechnologies provides innovative life science systems that reveal the complexity of biology for clinicians and scientists.
What stage is Kryptos Biotechnologies at?
Kryptos Biotechnologies is at the Series A stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Kryptos Biotechnologies — Funding & Investors." VCBacked, March 28, 2024, https://www.vcbacked.co/company/kryptos-biotechnologies. Accessed June 10, 2026.
APA
VCBacked. (2024). Kryptos Biotechnologies — Funding & Investors. Retrieved June 10, 2026, from https://www.vcbacked.co/company/kryptos-biotechnologies
Wikipedia (cite web)
{{cite web |title=Kryptos Biotechnologies — Funding & Investors |url=https://www.vcbacked.co/company/kryptos-biotechnologies |website=VCBacked |access-date=June 10, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .